Novel nanobody-161 binds tumor necrosis factor receptor 2 (TNFR2) to exert an anti-tumor effect but does not block TNFα-binding.
新型纳米抗体-161 与肿瘤坏死因子受体 2 (TNFR2) 结合,发挥抗肿瘤作用,但不阻断 TNFα 结合。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1694313
Huang Liang, Kong Chao, Hu Yuhao, Zhang Michael, Li Shuangqi, Wang Wanjing, Guan Hui, Lim Mei Ling, Zhang Zhen, Zhang Wenhai, Zheng Hailiang, Yan Xintian, Sun Xinglu, Lei Pan, Dai Shanshan, Wang Wenrong, Lu Linlin, Zhou Junma, Fan Shilong, Lang Guojun